Nextera Enterprises (CE) (USOTC:NXRA)
Historical Stock Chart
From Jul 2019 to Jul 2024
![Click Here for more Nextera Enterprises (CE) Charts. Click Here for more Nextera Enterprises (CE) Charts.](/p.php?pid=staticchart&s=NO%5ENXRA&p=8&t=15)
Nextera Enterprises, Inc. (OTCBB:NXRA) today reported financial results
for fiscal year ended December 31, 2006 included in its Annual Report
filed with the SEC on April 17, 2007.
Net sales for the fiscal year ended December 31, 2006 were $7.5 million.
Net sales for 2006 reflect the operating results of the Woodridge Labs
business from the March 9, 2006 acquisition date forward. Net sales for
the 2006 period include a $2.3 million charge for expected returns
related to the March 2007 voluntary recall of certain DermaFreeze365™
products sold in 2006. There were no sales reported for the 2005 period
as the Company had no business operations in 2005.
For the fiscal year ended December 31, 2006, Nextera recorded a net loss
of $7.3 million or $0.19, per share as compared to a net loss of $1.9
million or $0.07 per share, for the 2005 fiscal year. The 2006 year
included an aggregate charge of $2.5 million, or $0.06 per share, for
expected returns and a write-down of inventories related to the
March 2007 voluntary product recall and a $1.4 million, or $0.03 per
share, charge associated with the amortization of the step-up to fair
value in the inventory acquired from Woodridge Labs, as required by SFAS
141. Additionally, the 2006 year included a $0.3 million, or $0.01 per
share, restructuring charge associated with the relocation of the
corporate headquarters from Boston, Massachusetts to Panorama City,
California.
As of December 31, 2006, Nextera had cash on-hand of $0.6 million.
Outstanding debt under the Company’s credit
facility was $11.7 million at December 31, 2006, $1.3 million lower than
the initial debt balance at March 9, 2006. Contributing to the ability
of the Company to repay its debt was the receipt of $0.3 million with
respect to an indemnity claim under the purchase agreement for the
acquisition of the Woodridge Labs business. Nextera also had Federal and
State tax net operating loss carryforwards of approximately $55.6
million and $25.6 million, respectively, that expire between 2007 and
2026. A full valuation allowance is maintained on the Company’s
deferred tax assets, which includes the loss carry-forwards, due to the
uncertainty of utilization of the future tax benefits.
For the fiscal year ended December 31, 2006, non-cash charges were $2.8
million, or $0.07 per share. Non-cash charges included $1.4 million
related to the one-time inventory step-up charge, $0.8 million of
amortization of intangible assets and depreciation, $0.2 million each
for deferred tax expense relating to the goodwill generated in the
Woodridge Labs acquisition, stock-based compensation and inventory
write-downs.
The inventory step-up charge was associated with purchase accounting
resulting from the write-off of the step-up in the value of inventory
acquired from Woodridge Labs. Inventory was stepped-up to its current
fair market value in the acquisition and subsequently sold, results in a
higher cost of goods sold during the periods in which the stepped-up
inventory is sold. The resulting cost of goods sold and gross margins
were negatively impacted as compared to historical and future periods in
which the inventory sold represents the actual cost of products
produced. The inventory step-up charge was $0.3 million in first quarter
of 2006, $1.0 million in the second quarter of 2006 and $0.1 million in
the third quarter of 2006. No further inventory step-up charges will be
recorded in connection with the inventory acquired as part of the
acquisition of the Woodridge Labs business.
As a result of the 2006 financial impact of the March 2007 product
recall and lower than expected operating results during the fourth
quarter of 2006, the Company failed to comply with certain of its
original financial covenants under its credit facility. However, the
Company was successful in amending its financial covenants associated
with its credit facility to provide for the deferral of certain
covenants until 2008, as well as reducing the thresholds of other
covenants that remain in effect throughout 2007. Additionally, the
Company entered into various agreements with certain of its shareholders
to obtain $4.5 million in additional subordinated financing which was
funded during March and April 2007.
Joe Millin, President of Nextera Enterprises, said, “The
first year of Woodridge Labs operations under Nextera has been
demanding. We are managing through the DermaFreeze365™
product recall and there have been challenges in the mass retail space
in 2006, including consolidation of retailers and a move towards
retailer-specific proprietary brands. However, we feel Woodridge is
positioned well in our niche to manage these opportunities. In 2006 we
launched the Ellin LaVar Textures™ hair care
brand through exclusive distribution at a major retail pharmacy. Our
first product shipments from the Ellin Lavar line in late December
resulted in approximately $900,000 of revenue recognized in the first
quarter of 2007. In the first quarter of 2007 we also announced the
acquisition of the Heavy Duty™ personal care
brand with initial distribution in home-improvement retail, a sector
that Woodridge had not previously had a presence.”
“On the corporate front, in the first quarter
of 2007 we reset our bank loan covenants to better match our 2007
operating projections. This restructuring included $4.5 million of
financial support from existing shareholders to fund Nextera’s
2007 operations,” added Mr. Millin.
About Nextera Enterprises, Inc.
Nextera Enterprises Inc. operates through its wholly-owned subsidiary,
Woodridge Labs, Inc. Woodridge is an independent developer and
marketer of branded consumer products that offer simple, effective
solutions to niche personal care needs. More information can be found at www.nextera.com
and www.woodridgelabs.com.
Forward-Looking Statements
This release contains forward-looking statements that involve risks and
uncertainties, including, but not limited to, estimates of future
performance. Actual results may differ materially from the results
predicted, and reported results should not be considered an indication
of future performance. Important factors that could cause actual results
to differ materially from those expressed or implied in the
forward-looking statements are detailed under “Item
1A.Risk Factors” and elsewhere in filings
with the Securities and Exchange Commission made from time to time by
Nextera, including, but not limited to: its Annual Report on Form 10-K
for the year ended December 31, 2006 filed with the Securities and
Exchange Commission on April 17, 2007; recent quarterly reports on Form
10-Q; and other current reports on Form 8-K. All forward-looking
statements included in this news release should be considered in the
context of these risk factors. Nextera undertakes no obligation to
release publicly any revisions to any forward-looking statements to
reflect events or circumstances after the date hereof or to reflect the
occurrence of unanticipated events. Investors and prospective investors
are cautioned not to place undue reliance on such forward-looking
statements.
NEXTERA ENTERPRISES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(amounts in thousands, except per share amounts)
Year Ended
December 31,
2006
2005
Net revenue
$
7,481
$
--
Cost of sales
5,307
--
Gross profit
2,174
--
Selling, general and administrative expenses
7,775
2,054
Amortization of intangible assets
726
--
Operating loss
(6,327)
(2,054)
Interest income
193
287
Interest expense
(1,016)
--
Other expense
--
(188)
Loss from continuing operations before income taxes
(7,150)
(1,955)
Provision for income taxes
236
24
Loss from continuing operations
(7,386)
(1,979)
Income from discontinued operations
69
78
Net loss
$
(7,317)
$
(1,901)
Preferred stock dividends
(353)
(328)
Net loss applicable to common stockholders
$
(7,670)
$
(2,229)
Net loss per common share, basic and diluted, from continuing
operations
$
(0.19)
$
(0.07)
Discontinued operations
0.00
0.00
Net loss per common share, basic and diluted
$
(0.19)
$
(0.07)
Weighted average common shares outstanding, basic and diluted
40,738
33,870
NEXTERA ENTERPRISES, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(amounts in thousands)
December 31,
ASSETS
2006
2005
CURRENT ASSETS:
Cash and cash equivalents
$
597
$
15,043
Inventories
2,595
--
Other current assets
387
128
Total current assets
3,579
15,171
Goodwill
10,969
--
Intangible assets
12,827
--
Other assets
768
64
Total assets
$
28,143
$
15,235
LIABILITIES AND STOCKHOLDERS' EQUITY
Accounts payable and accrued expenses
$
4,364
$
542
Total current liabilities
4,364
542
Long-term debt
11,718
--
Deferred tax liability
236
--
Other long-term liabilities
1,334
1,334
Total stockholders' equity
10,491
13,359
Total liabilities and stockholders' equity
$
28,143
$
15,235